Hospital Clinico Universitario De Valencia — Clinical Trial Site

655 Registered trials

275 Currently recruiting

Organisation

Hospital Clinico Universitario De Valencia

Location

Valencia, Spain

Identifier

ORG-100032606

Address

Avenida Blasco Ibanez 17, 46010, Spain

Departments

#034004 Oncología
#1403: Oncología
#2318:servicio de neurología
#2503: Oncología Médica
#4004:Hematología
#4213:Servicio de Endocronología y Nutrición
#4503: Cardiología
#7003: Oncología Medica
#7005:Oncology
#8004: Oncología Médica
#9005: Oncology
034-05: Oncologia Médica y Hematologia
03405:Oncologia Médica y Hematologia
1203:Oncología Médica
1304: Oncología
1317: Oncologia Médica y Hematologia
1603:Oncología
2404: Reumatología
2404:Rheumatology
2601: Cardiology
2605:Urology
2803: Cardiologia
3102: Oncología.
3106: neurologia
3150: Cardiología
3278:Urologia
3307: Oncologia
3502: Cardiologia
5103: Servicio Oncología
5509: Neumologia
7002
7005: Oncology
7006: Oncología
7006: Oncologia Médica y Hematologia
7006:Oncología
7007; Oncology
7010: Anestesiología y Reanimación
724005: Oncologia Médica y Hematologia
9404:Oncologia Médica y Hematologia
ALERGOLOGÍA
Allergology
Anaesthesia Department
Anaesthesia. Resuscitation and Pain Unit
Anestesia
Anestesiología y Reanimación
Anesthesia
Anesthesiology
Anesthesiology and Reanimation
Aparato Digestivo
Cardiologia
Cardiology
Cardiology department
Cirugía
Clinical Haematology
Department of Anesthesiology and Surgical-Trauma Intensive Care
Department of Hematology
Department of Hematology and Medical Oncology
Department of Neurology
Dermatology
Digestive
Digestive Department
Digestive Medicine
Endocrinología
Endocrinology
Ensayos Clinicos
ES10007: Gastroenterologia
ESP0604: Oncologia Médica y Hematologia
Gastroenterology
Gastroenterology and Hepatology
General Surgery
Haematology
Hematologia
Hematología y Oncología
Hematology
Hematology & Hemotherapy
Hematology and Medical Oncology
Hematology and Medical Oncology Service
Hematology and Oncology
Hematology Department
Hematology Service
Hematology Service and Hemotherapy Service
Hepatología
Hepatology Service
Hospital Clínico Universitario
Hospital Clínico Universitario de Valencia
INCLIVA - Biomedical Research Institute
INCLIVA Biomedical Research Institute. Hospital Clínico Universitario of Valencia
Infectious Diseases
Instituto de Investigación Sanitaria INCLIVA
Intensive Medicine
Internal Medicine
Interventional Cardiology
Materno Infantil - Servicio Oncologia
Medica Oncology
Medical Doctor
Medical Oncology
Medical Oncology and Hematology
Medical Oncology Department
Medical Oncology Service
Medical Oncology, Phase I Unit
Medicina Digestiva
Medicine
Medidla oncologist
n/a
NA
Nefrologia
Nefrology
Nephrology
Nephrology Service
Nesthesiology
Neumologia
Neumology
Neurología
Neurology
Onclogy
Oncología
Oncologia Medica
Oncologia Médica y Hematologia
Oncología y Hematología
Oncology
Oncology and Hematology
Oncology and Medical Hematology
Oncology Department
Oncology service
Oncology Service Department
Oncology Service.
Onology
Pain Unit
Pediatría
Pediatric Oncology and Hematology
Pediatric oncology and hematology department
Pediatric oncology department
Pediatríc Unit
Phase I and Precision Medicine Unit
Pneumology
Pneumology Department
Pneumology Service
Psychiatry Department
Pulmonology
Respiratory medicine
Rheumatologist
Rheumatology
Sempere
Servicio de digestivo
Servicio Cardiología
Servicio de Cardiología
Servicio de Digestivo
Servicio de Endocrinologia
Servicio de endocrinologia y nutricion
Servicio de Hematologia
Servicio de Hematología y Oncología
Servicio de Hematología y Oncología Médica
Servicio de Hematologia y Oncologia, INCLIVA. Edificio Maternidad.
Servicio de Neumología
Servicio de Oncología
Servicio de Oncología Médica
Servicio de Oncología Médica y Hematología
Servicio de Reumatología
Servicio Neumologia
Servicio Oncología
Stroke Unit
Unidad del Dolor dentro del departamento SARTD
Urology

Clinical trials at this site (655)

Search interface

COLCHICINE IN SECONDARY PREVENTION OF VASCULAR EVENTS AND RENAL PROGRESSION IN PATIENTS WITH MODERATE CHRONIC RENAL DISEASE Recruiting

2023-505868-11-00 CHRONIC RENAL DISEASE 5 2025-01-17
Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-resistant Patients Scheduled to Undergo … Recruiting

2023-507560-39-00 Acquired Antithrombin Deficiency (Heparin Resistance) 5 2025-01-07
Evaluating how well and how safely Alisertib works with hormone therapy in treating patients with breast cancer that has come back or spread… Recruiting

2024-511497-79-00 Hormone receptor positive (HR+), human epidermal growth 4 2024-12-30
Efficacy of DEXamethasone in Patients With Acute Hypoxemic REspiratory Failure Caused by INfEctions (DEXA-REFINE) Recruiting

2024-519759-27-00 Acute Hypoxemic Respiratory Failure 6 2024-12-20
Treatment with a single drug that prevents blood clot formation followed by an anticoagulant drug in patients with irregular heartbeat who h… Recruiting

2023-509717-36-00 AF patients who have undergone successful PCI 5 2024-12-16
A Phase 3, randomized, open-label, multicenter, controlled study to evaluate the efficacy and safety of zanidatamab in combination with phys… Recruiting

2023-508960-31-00 Metastatic HER2-positive breast cancer 5 2024-12-03
A study to test long-term treatment with brigimadlin in people with solid tumours who took part in a previous study with this medicine Recruiting

2024-514177-21-00 Solid tumours 4 2024-12-02
A Phase 2, open label, randomized study of neoadjuvant dostarlimab plus CAPEOX versus CAPEOX in participants with previously untreated T4N0 … Recruiting

2024-513441-36-00 MMRp/ MSS colon cancer 4 2024-11-27
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician’s Choice in Patients With Triple Negative Breast Cancer … Recruiting

2024-512279-10-00 Triple Negative Breast Cancer 5 2024-11-25
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects with Compensate… Recruiting

2024-512895-36-00 Non Alcoholic Steatohepatitis (NASH) 5 2024-11-25
A Study of ZL-1310 in Patients with Small Cell Lung Cancer to Find a Suitable Dose and to Test How Different Doses of ZL-1310 are Tolerated … Recruiting

2024-514446-36-00 Small Cell Lung Cancer 1 2024-11-21
LATE-R trial. A Phase II, Single-Arm, Open-Label, Multicenter Study to Evaluate the Efficacy of Axicabtagene Ciloleucel in Patients with Lat… Recruiting

2024-512835-53-00 Diffuse Large B-Cell Lymphoma 4 2024-11-20
Randomised, double-blind, multicentre, phase III clinical trial to evaluate the efficacy and safety of dexamethasone compared to placebo in … Recruiting

2024-513209-30-00 Severe Influenza 5 2024-11-20
A first-in-human study of PARP1 selective inhibitor, IMP1734, in patients with advanced solid tumors. Recruiting

2023-509230-19-00 Advance solid tumors 7 2024-11-14
Letermovir (LMV) prophylaxis in CMV-seronegative Allogeneic Stem Cell Transplant Recipients with CMV seropositive donors Recruiting

2024-516011-24-01 Cytomegalovirus infection in allogeneic stem cell trans 4 2024-11-13
A study to test if different doses of D3S-001 used on its own or in combination with other anti-cancer medicines is safe and tolerable in pe… Recruiting

2023-508517-16-00 Advanced Solid Tumors with a KRAS p.G12C Mutation 7 2024-11-10
Immunotherapy and chemotherapy treatment or no treatment guided by the level of tumour-infiltrating cells in resected early-stage triple-neg… Recruiting

2023-504620-26-00 Triple negative breast cancer 4 2024-11-04
Phase 1/2 study testing for the first time in humans a novel drug, STAR0602, to selectively stimulate T cells for the treatment of subjects … Recruiting

2023-505334-10-01 Unresectable, Locally Advanced, or Metastatic Solid Tum 7 2024-10-30
A study to test whether vicadrostat (BI 690517) in combination with empagliflozin helps people with heart failure. Recruiting

2023-509706-30-00 Heart failure (HF) 5 2024-10-18
Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis Recruiting

2023-504724-25-00 Primary Myelofibrosis 5 2024-10-16
An international multicentric randomized phase II evaluating dostarlimab in combination with niraparib versus niraparib alone compared to ch… Recruiting

2024-516782-36-00 metastatic or recurrent endometrial or ovarian carcinos 4 2024-10-15
202301CPC Redefine-HF Recruiting

2023-508581-15-00 Heart condition 5 2024-10-08
A Randomized Clinical Trial, Multicentre, Open-label, Parallel-group, to define the best Strategy for the management of hEart failure aNd ch… Recruiting

2024-513971-42-00 Chronic heart failure (NYHA I-III) and non-dialysis CKD 5 2024-10-01
First-in-human Trial of EGL-001 in Patients with Selected Advanced and/or Metastatic Solid Tumors Recruiting

2024-512921-10-00 Advanced and/or Metastatic Solid Tumors 1 2024-09-27